11 results on '"Graham, Gerard J."'
Search Results
2. International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors
- Author
-
Bachelerie, Francoise, Ben-Baruch, Adit, Burkhardt, Amanda M, Combadiere, Christophe, Farber, Joshua M, Graham, Gerard J, Horuk, Richard, Sparre-Ulrich, Alexander Hovard, Locati, Massimo, Luster, Andrew D, Mantovani, Alberto, Matsushima, Kouji, Murphy, Philip M, Nibbs, Robert, Nomiyama, Hisayuki, Power, Christine A, Proudfoot, Amanda EI, Rosenkilde, Mette M, Rot, Antal, Sozzani, Silvano, Thelen, Marcus, Yoshie, Osamu, and Zlotnik, Albert
- Subjects
Biomedical and Clinical Sciences ,Immunology ,Biotechnology ,Genetics ,Inflammatory and immune system ,Animals ,Arthropod Proteins ,Humans ,Protozoan Proteins ,Receptors ,Chemokine ,Terminology as Topic ,Ticks ,Viral Proteins ,Pharmacology and Pharmaceutical Sciences ,Pharmacology & Pharmacy ,Pharmacology and pharmaceutical sciences - Abstract
Sixteen years ago, the Nomenclature Committee of the International Union of Pharmacology approved a system for naming human seven-transmembrane (7TM) G protein-coupled chemokine receptors, the large family of leukocyte chemoattractant receptors that regulates immune system development and function, in large part by mediating leukocyte trafficking. This was announced in Pharmacological Reviews in a major overview of the first decade of research in this field [Murphy PM, Baggiolini M, Charo IF, Hébert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, and Power CA (2000) Pharmacol Rev 52:145-176]. Since then, several new receptors have been discovered, and major advances have been made for the others in many areas, including structural biology, signal transduction mechanisms, biology, and pharmacology. New and diverse roles have been identified in infection, immunity, inflammation, development, cancer, and other areas. The first two drugs acting at chemokine receptors have been approved by the U.S. Food and Drug Administration (FDA), maraviroc targeting CCR5 in human immunodeficiency virus (HIV)/AIDS, and plerixafor targeting CXCR4 for stem cell mobilization for transplantation in cancer, and other candidates are now undergoing pivotal clinical trials for diverse disease indications. In addition, a subfamily of atypical chemokine receptors has emerged that may signal through arrestins instead of G proteins to act as chemokine scavengers, and many microbial and invertebrate G protein-coupled chemokine receptors and soluble chemokine-binding proteins have been described. Here, we review this extended family of chemokine receptors and chemokine-binding proteins at the basic, translational, and clinical levels, including an update on drug development. We also introduce a new nomenclature for atypical chemokine receptors with the stem ACKR (atypical chemokine receptor) approved by the Nomenclature Committee of the International Union of Pharmacology and the Human Genome Nomenclature Committee.
- Published
- 2014
3. Diverse myeloid cells are recruited to the developing and inflamed mammary gland.
- Author
-
Wilson, Gillian J., Fukuoka, Ayumi, Vidler, Francesca, and Graham, Gerard J.
- Subjects
MYELOID cells ,MAMMARY glands ,CELL receptors ,IMMUNE system - Abstract
The immune system plays fundamental roles in the mammary gland, shaping developmental processes and controlling inflammation during infection and cancer.Here, we reveal unanticipated heterogeneity in the myeloid cell compartment duringdevelopment of virgin, pregnant, lactating and involuting mouse mammary glands,and in milk. We investigate the functional consequences of individual and compoundchemokine receptor deficiency on cell recruitment. Diverse myeloid cell recruitmentwas also shown in models of sterile inflammation and bacterial infection.Strikingly, we have shown that inflammation and infection can alter the abundanceof terminal end buds, a key developmental structure, within the pubertal mammarygland. This previously unknown effect of inflammatory burden during puberty couldhave important implications for understanding pubertal development. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. The chemokine receptors ACKR2 and CCR2 reciprocally regulate lymphatic vessel density
- Author
-
Lee, Kit M., Danuser, Renzo, Stein, Jens V., Graham, Delyth, Nibbs, Robert J.B., and Graham, Gerard J.
- Subjects
Mice, Knockout ,Receptors, CCR2 ,Macrophages ,chemokine ,610 Medicine & health ,Articles ,macrophage ,Embryo, Mammalian ,lymphatic ,Mice ,atypical receptors ,Animals ,Receptors, Chemokine ,Lymph Nodes ,Lymphangiogenesis ,development ,Lymphatic Vessels ,Skin - Abstract
Macrophages regulate lymphatic vasculature development; however, the molecular mechanisms regulating their recruitment to developing, and adult, lymphatic vascular sites are not known. Here, we report that resting mice deficient for the inflammatory chemokine-scavenging receptor, ACKR2, display increased lymphatic vessel density in a range of tissues under resting and regenerating conditions. This appears not to alter dendritic cell migration to draining lymph nodes but is associated with enhanced fluid drainage from peripheral tissues and thus with a hypotensive phenotype. Examination of embryonic skin revealed that this lymphatic vessel density phenotype is developmentally established. Further studies indicated that macrophages and the inflammatory CC-chemokine CCL2, which is scavenged by ACKR2, are associated with this phenotype. Accordingly, mice deficient for the CCL2 signalling receptor, CCR2, displayed a reciprocal phenotype of reduced lymphatic vessel density. Further examination revealed that proximity of pro-lymphangiogenic macrophages to developing lymphatic vessel surfaces is increased in ACKR2-deficient mice and reduced in CCR2-deficient mice. Therefore, these receptors regulate vessel density by reciprocally modulating pro-lymphangiogenic macrophage recruitment, and proximity, to developing, resting and regenerating lymphatic vessels.
- Published
- 2014
- Full Text
- View/download PDF
5. Chemokine receptors coordinately regulate macrophage dynamics and mammary gland development.
- Author
-
Wilson, Gillian J., Fukuoka, Ayumi, Love, Samantha R., Kim, Jiwon, Pingen, Marieke, Hayes, Alan J., and Graham, Gerard J.
- Subjects
MAMMARY glands ,CHEMOKINE receptors ,BREAST cancer ,PUBERTY ,EPITHELIUM ,MACROPHAGES - Abstract
Macrophages are key regulators of developmental processes, including those involved in mammary gland development. We have previously demonstrated that the atypical chemokine receptor ACKR2 contributes to the control of ductal epithelial branching in the developing mammary gland by regulating macrophage dynamics. ACKR2 is a chemokine-scavenging receptor that mediates its effects through collaboration with inflammatory chemokine receptors (iCCRs). Here, we reveal reciprocal regulation of branching morphogenesis in the mammary gland, whereby stromal ACKR2 modulates levels of the shared ligand CCL7 to control the movement of a key population of CCR1-expressing macrophages to the ductal epithelium. In addition, oestrogen, which is essential for ductal elongation during puberty, upregulates CCR1 expression onmacrophages. The age at which girls develop breasts is decreasing, which raises the risk of diseases including breast cancer. This study presents a previously unknown mechanismcontrolling the rate of mammary gland development during puberty and highlights potential therapeutic targets. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
6. Elevated ACKR2 expression is a common feature of inflammatory arthropathies.
- Author
-
Baldwin, Helen M., Singh, Mark D., Codullo, Veronica, King, Vicky, Wilson, Hilary, McInnes, Iain, and Graham, Gerard J.
- Subjects
CHEMOKINES ,CYTOKINES ,GENE expression ,IMMUNOHISTOCHEMISTRY ,INFLAMMATION ,POLYMERASE chain reaction ,RESEARCH funding ,SPONDYLOARTHROPATHIES ,DATA analysis software ,DESCRIPTIVE statistics - Abstract
Objectives. Chemokines are essential contributors to leucocyte accumulation at sites of inflammatory pathology. Interfering with chemokine or chemokine receptor function therefore represents a plausible therapeutic option. However, our currently limited understanding of chemokine orchestration of inflammatory responses means that such therapies have not yet been fully developed. We have a particular interest in the family of atypical chemokine receptors that fine-tune, or resolve, chemokine-driven responses. In particular we are interested in atypical chemokine receptor 2 (ACKR2), which is a scavenging receptor for inflammatory CC-chemokines and that therefore helps to resolve in vivo inflammatory responses. The objective of the current study was to examine ACKR2 expression in common arthropathies. Methods. ACKR2 expression was measured by a combination of qPCR and immuno-histochemistry. In addition, circulating cytokine and chemokine levels in patient plasma were assessed using multiplexing approaches. Results. Expression of ACKR2 was elevated on peripheral blood cells as well as on leucocytes and stromal cells in synovial tissue. Expression on peripheral blood leucocytes correlated with, and could be regulated by, circulating cytokines with particularly strong associations being seen with IL-6 and hepatocyte growth factor. In addition, expression within the synovium was coincident with aggregates of lymphocytes, potentially atopic follicles and sites of high inflammatory chemokine expression. Similarly increased levels of ACKR2 have been reported in psoriasis and SSc. Conclusion. Our data clearly show increased ACKR2 in a variety of arthropathies and taking into account our, and others', previous data we now propose that elevated ACKR2 expression is a common feature of inflammatory pathologies. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
7. Chemokine CXCL4 interactions with extracellular matrix proteoglycans mediate widespread immune cell recruitment independent of chemokine receptors.
- Author
-
Gray, Anna L., Karlsson, Richard, Roberts, Abigail R.E., Ridley, Amanda J.L., Pun, Nabina, Khan, Bakhtbilland, Lawless, Craig, Luís, Rafael, Szpakowska, Martyna, Chevigné, Andy, Hughes, Catherine E., Medina-Ruiz, Laura, Birchenough, Holly L., Mulholland, Iashia Z., Salanga, Catherina L., Yates, Edwin A., Turnbull, Jeremy E., Handel, Tracy M., Graham, Gerard J., and Jowitt, Thomas A.
- Abstract
Leukocyte recruitment from the vasculature into tissues is a crucial component of the immune system but is also key to inflammatory disease. Chemokines are central to this process but have yet to be therapeutically targeted during inflammation due to a lack of mechanistic understanding. Specifically, CXCL4 (Platelet Factor 4, PF4) has no established receptor that explains its function. Here, we use biophysical, in vitro , and in vivo techniques to determine the mechanism underlying CXCL4-mediated leukocyte recruitment. We demonstrate that CXCL4 binds to glycosaminoglycan (GAG) sugars on proteoglycans within the endothelial extracellular matrix, resulting in increased adhesion of leukocytes to the vasculature, increased vascular permeability, and non-specific recruitment of a range of leukocytes. Furthermore, GAG sulfation confers selectivity onto chemokine localization. These findings present mechanistic insights into chemokine biology and provide future therapeutic targets. [Display omitted] • CXCL4 (PF4) mediates non-specific recruitment of a range of immune cells • CXCL4 functions by binding to glycosaminoglycans on endothelial proteoglycans • CXCL4 cross-linking of glycosaminoglycans produces endothelial signaling • Glycosaminoglycan sulfation mediates specific chemokine interactions Chemokines are central to immune cell recruitment but have not been therapeutically targeted during inflammation due to lack of full understanding of their action mechanisms. Gray et al. show that CXCL4 binds to endothelial extracellular matrix proteoglycans producing immune cell recruitment. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Regulation of the immune and inflammatory responses by the 'atypical' chemokine receptor D6.
- Author
-
Graham, Gerard J and Locati, Massimo
- Abstract
Chemokines and their receptors are key regulators of leukocyte migration and intra-tissue accumulation under both homeostatic and inflammatory conditions. Regulation of chemokine-dependent responses, particularly those relating to inflammation, is essential to avoid the development of inflammatory and autoimmune pathologies. Recently, a new subfamily of chemokine receptors referred to as the 'atypical' chemokine receptors has emerged, members of which have been shown to play important roles in controlling in vivo chemokine biology. Here we review the basic biology of the chemokine and chemokine receptor family, introduce the topic of 'atypical' chemokine receptor biology and focus specifically on the best-characterized of the 'atypical' chemokine receptors, D6. D6 is a 'scavenging' receptor for inflammatory CC chemokines and plays a central role in the resolution of in vivo inflammatory responses. We describe the biology, biochemistry and pathological relevance of D6 and outline emerging data suggesting that it has additional important roles in integrating innate and adaptive immune responses. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
9. Astrocytes modulate the chemokine network in a pathogen-specific manner
- Author
-
McKimmie, Clive S. and Graham, Gerard J.
- Subjects
- *
ASTROCYTES , *CHEMOKINES , *IMMUNOREGULATION , *BLOOD-brain barrier , *NATURAL immunity , *NEUROIMMUNOLOGY , *CENTRAL nervous system , *LEUCOCYTES - Abstract
Abstract: Immune responses in the central nervous system (CNS) are carefully regulated. Despite the absence of most immune processes and a substantive blood brain barrier, potent immune responses form during infection and autoimmunity. Astrocytes are innate immune sentinels that ensheath parenchymal blood vessels and sit at the gateway to the CNS parenchyma. Viral and bacterial infections trigger the influx of distinct leukocyte subsets. We show that astrocytes alone are sufficient for distinguishing between these two main types of infection and triggers release of relevant chemokines that relate to the microbe recognised. Bacterial-associated molecules induced the preferential expression of CCL2, CXCL1, CCL20 and CCL3 whilst a virus-associated dsRNA analogue preferentially up-regulated CXCL10 and CCL5. Thus, astrocytes can respond to infection in a distinct and appropriate manner suggesting they have the capacity to attract appropriate sets of leukocytes into the brain parenchyma. Astrocytes themselves are unable to respond to these chemokines since they were devoid of most chemokine receptors but expressed CXCR4, CXCR7 and CXCR6 at rest. Stimulation with TGF-β specifically up-regulated CXCR6 expression and may explain how TGF-β/CXCL16-expressing gliomas are so effective at attracting astroglial cells. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
10. New nomenclature for atypical chemokine receptors
- Author
-
Bachelerie Françoise, Graham Gerard J., Locati Massimo, Mantovani Alberto, Murphy Philip M., Nibbs Robert, Rot Antal, Sozzani Silvano, and Thelen Marcus
- Subjects
0303 health sciences ,Chemokine ,biology ,Immunology ,C-C chemokine receptor type 6 ,03 medical and health sciences ,Chemokine receptor ,0302 clinical medicine ,Terminology as Topic ,030220 oncology & carcinogenesis ,Cancer research ,biology.protein ,Humans ,Immunology and Allergy ,Receptors, Chemokine ,CXC chemokine receptors ,Receptor ,Nomenclature ,030304 developmental biology ,CCL21
11. Role of inflammatory chemokines in hypertension.
- Author
-
Mikolajczyk, Tomasz P., Szczepaniak, Piotr, Vidler, Francesca, Maffia, Pasquale, Graham, Gerard J., and Guzik, Tomasz J.
- Subjects
- *
CHEMOKINES , *HYPERTENSION , *REGULATION of blood pressure , *BLOOD pressure , *DRUG target , *HEART failure - Abstract
Hypertension is associated with immune cells activation and their migration into the kidney, vasculature, heart and brain. These inflammatory mechanisms are critical for blood pressure regulation and mediate target organ damage, creating unique novel targets for pharmacological modulation. In response to angiotensin II and other pro-hypertensive stimuli, the expression of several inflammatory chemokines and their receptors is increased in the target organs, mediating homing of immune cells. In this review, we summarize the contribution of key inflammatory chemokines and their receptors to increased accumulation of immune cells in target organs and effects on vascular dysfunction, remodeling, oxidative stress and fibrosis, all of which contribute to blood pressure elevation. In particular, the role of CCL2, CCL5, CXCL8, CXCL9, CXCL10, CXCL11, CXCL16, CXCL1, CX3CL1, XCL1 and their receptors in the context of hypertension is discussed. Recent studies have tested the efficacy of pharmacological or genetic targeting of chemokines and their receptors on the development of hypertension. Promising results indicate that some of these pathways may serve as future therapeutic targets to improve blood pressure control and prevent target organ consequences including kidney failure, heart failure, atherosclerosis or cognitive impairment. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.